BIONET Corp. (1784.TWO)

TWD 79.5

(-3.52%)

Market Cap (In TWD)

4.04 Billion

Revenue (In TWD)

1.12 Billion

Net Income (In TWD)

78.39 Million

Avg. Volume

2.33 Million

Currency
TWD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
50.767708-162.00966
PE
-
EPS
-
Beta Value
0.712
ISIN
TW0001784007
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Qianyu Liu
Employee Count
-
Website
https://www.bionetcorp.com
Ipo Date
2007-12-31
Details
BIONET Corp. provides cord blood banking services in Taiwan and internationally. The company offers stem cell banking services, including stem cell storage, mesenchymal stem cell storage, dental stem cell storage, adipose stem cell, and PBSC + immune cells; and genetic testing services. It also provides stem anti-aging and ANIKINE series products. In addition, the company offers Exosome, a novel cell-free therapy. The company was founded in 1989 and is based in Taipei City, Taiwan.

More Stocks